Prestige Consumer Healthcare
PBH
232 hedge funds and large institutions have $2.85B invested in Prestige Consumer Healthcare in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 96 increasing their positions, 77 reducing their positions, and 37 closing their positions.
230,742% more call options, than puts
Call options by funds: $27.7M | Put options by funds: $12K
25% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 77
2.21% more ownership
Funds ownership: 99.55% → 101.77% (+2.2%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less capital invested
Capital invested by funds: $2.93B → $2.85B (-$82.1M)
3% less funds holding
Funds holding: 240 → 232 (-8)
16% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$49.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$37.2M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$21.4M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$19.2M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
+$15.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$36.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$30.1M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$21M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$12.5M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$11.9M |
PBH Hedge Fund Activity: Q2 2017 in Review
232 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q2 2017, worth a combined $2.85B — down 2.8% from $2.93B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of PBH and 31 opened new positions — a net loss of 6 holders — while 77 trimmed existing stakes and 96 added.
The largest buyer was Fidelity Investments, adding an estimated $49.7M. The largest seller was BlackRock, cutting an estimated $36.3M.
- 232 institutional investors held Prestige Consumer Healthcare (PBH) as of Q2 2017, down from 240 in Q1 2017.
- Funds reported $2.85B of Prestige Consumer Healthcare stock for Q2 2017, down 2.8% quarter-over-quarter.
- 31 funds opened new Prestige Consumer Healthcare positions in Q2 2017 and 37 closed out, a net change of -6 holders.
- The largest Prestige Consumer Healthcare buyer in Q2 2017 was Fidelity Investments, an estimated $49.7M added.
- The largest Prestige Consumer Healthcare seller in Q2 2017 was BlackRock, an estimated $36.3M sold.
Based on aggregated 13F filings for Q2 2017.